Live Quote · NASDAQNAMSHealthcare· Biotechnology

NewAmsterdam Pharma Company N.V.

$18.41▼ 5.64%($-1.10)
MKT CAP $2.21BNEXT EARNINGS Feb 17, 2027
50%
Bullish
TickerSpark Score
52/100
▌ Mixed
53
Valuation
40
Profitability
55
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NAMS research report →

Analyst Price Target
$53.75+192.0% vs. today

Range $45 – $61

Analyst RatingBuy
10 Buy1 Hold0 Sell

Price Chart

-51.18% · this period
$41.45$29.93$18.41Nov 20May 26Nov 20
52-Week Range2% of range
Low
$17.90
Current
$18.41
High
$42.21